163 related articles for article (PubMed ID: 10358197)
1. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375.
Itoh S; Hattori T; Hayashi H; Mizutani Y; Todo M; Takii T; Yang D; Lee JC; Matsufuji S; Murakami Y; Chiba T; Onozaki K
J Immunol; 1999 Jun; 162(12):7434-40. PubMed ID: 10358197
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1-induced growth inhibition of human melanoma cells. Interleukin-1-induced antizyme expression is responsible for ornithine decarboxylase activity down-regulation.
Yang D; Hayashi H; Takii T; Mizutani Y; Inukai Y; Onozaki K
J Biol Chem; 1997 Feb; 272(6):3376-83. PubMed ID: 9013579
[TBL] [Abstract][Full Text] [Related]
3. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription.
Baldassare JJ; Bi Y; Bellone CJ
J Immunol; 1999 May; 162(9):5367-73. PubMed ID: 10228013
[TBL] [Abstract][Full Text] [Related]
4. CHOP, a basic leucine zipper transcriptional factor, contributes to the antiproliferative effect of IL-1 on A375 human melanoma cells through augmenting transcription of IL-6.
Hattori T; Itoh S; Hayashi H; Chiba T; Takii T; Yoshizaki K; Onozaki K
J Interferon Cytokine Res; 2001 May; 21(5):323-32. PubMed ID: 11429163
[TBL] [Abstract][Full Text] [Related]
5. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375.
Hattori T; Hayashi H; Chiba T; Onozaki K
Eur Cytokine Netw; 2001; 12(2):244-52. PubMed ID: 11399512
[TBL] [Abstract][Full Text] [Related]
6. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
7. Contribution of extracellular signal-regulated kinases to the IL-1-induced growth inhibition of human melanoma cells A375.
Arakawa T; Yamamura T; Hattori T; Hayashi H; Mori A; Yoshida A; Uchida C; Kitagawa M; Onozaki K
Int Immunopharmacol; 2008 Jan; 8(1):80-9. PubMed ID: 18068103
[TBL] [Abstract][Full Text] [Related]
8. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
Swart JM; Bergeron DM; Chiles TC
J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
[TBL] [Abstract][Full Text] [Related]
9. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production.
Chang CI; Zoghi B; Liao JC; Kuo L
J Immunol; 2000 Aug; 165(4):2134-41. PubMed ID: 10925299
[TBL] [Abstract][Full Text] [Related]
10. Transfection of human melanoma cells with type I interleukin-1 (IL-1) receptor cDNA rendered them IL-1-responsive and revealed the importance of ODC activity down-regulation in IL-1-induced growth inhibition.
Yang D; Hayashi H; Hiyama Y; Takii T; Onozaki K
J Biochem; 1995 Oct; 118(4):802-9. PubMed ID: 8576096
[TBL] [Abstract][Full Text] [Related]
11. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production.
Koprak S; Staruch MJ; Dumont FJ
Cell Immunol; 1999 Mar; 192(2):87-95. PubMed ID: 10087176
[TBL] [Abstract][Full Text] [Related]
12. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
Craxton A; Shu G; Graves JD; Saklatvala J; Krebs EG; Clark EA
J Immunol; 1998 Oct; 161(7):3225-36. PubMed ID: 9759836
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors.
Flamigni F; Facchini A; Giordano E; Tantini B; Stefanelli C
Biochem Pharmacol; 2001 Jan; 61(1):25-32. PubMed ID: 11137705
[TBL] [Abstract][Full Text] [Related]
14. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
15. p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells.
Schafer PH; Wadsworth SA; Wang L; Siekierka JJ
J Immunol; 1999 Jun; 162(12):7110-9. PubMed ID: 10358155
[TBL] [Abstract][Full Text] [Related]
16. p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells.
Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Takeshita I; Hayashi S; Koura T; Kujime K; Horie T
Eur Respir J; 1999 Jun; 13(6):1357-64. PubMed ID: 10445612
[TBL] [Abstract][Full Text] [Related]
17. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels.
Ridley SH; Sarsfield SJ; Lee JC; Bigg HF; Cawston TE; Taylor DJ; DeWitt DL; Saklatvala J
J Immunol; 1997 Apr; 158(7):3165-73. PubMed ID: 9120270
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts.
Kozawa O; Tokuda H; Matsuno H; Uematsu T
J Cell Biochem; 1999 Sep; 74(3):479-85. PubMed ID: 10412048
[TBL] [Abstract][Full Text] [Related]
19. p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis.
Mori A; Kaminuma O; Miyazawa K; Ogawa K; Okudaira H; Akiyama K
J Immunol; 1999 Nov; 163(9):4763-71. PubMed ID: 10528175
[TBL] [Abstract][Full Text] [Related]
20. Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.
Nakao T; Kim S; Ohta K; Kawano H; Hino M; Miura K; Tatsumi N; Iwao H
Br J Pharmacol; 2002 Aug; 136(7):975-84. PubMed ID: 12145097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
